Sriwidodo , Umar A, Wathoni N, Zothantluanga J, Das S, Luckanagul J
Heliyon. 2022; 8(2):e08934.
PMID: 35243059
PMC: 8861389.
DOI: 10.1016/j.heliyon.2022.e08934.
Kim T, Park J, Kim D, Gautam A, Akauliya M, Kim J
Int J Mol Sci. 2019; 20(14).
PMID: 31295956
PMC: 6678731.
DOI: 10.3390/ijms20143397.
Gupta J, Pathak M, Misra S, Misra-Bhattacharya S
Parasitol Res. 2019; 118(6):1943-1952.
PMID: 31069533
DOI: 10.1007/s00436-019-06318-6.
Kim T, Kim D, Gautam A, Lee H, Kwak M, Park M
Sci Rep. 2018; 8(1):16236.
PMID: 30390012
PMC: 6214913.
DOI: 10.1038/s41598-018-34722-y.
Kwon S, Kim Y, Park J, Kim D, Kwon H, Lee Y
BMB Rep. 2013; 47(4):215-20.
PMID: 24286311
PMC: 4163885.
DOI: 10.5483/bmbrep.2014.47.4.157.
Prevention and therapy of hepatocellular carcinoma by vaccination with TM4SF5 epitope-CpG-DNA-liposome complex without carriers.
Kwon S, Kim D, Park B, Cho S, Kim K, Kim Y
PLoS One. 2012; 7(3):e33121.
PMID: 22427965
PMC: 3299740.
DOI: 10.1371/journal.pone.0033121.
Production of antibodies with peptide-CpG-DNA-liposome complex without carriers.
Kim D, Kwon S, Rhee J, Kim K, Kim Y, Park C
BMC Immunol. 2011; 12:29.
PMID: 21592346
PMC: 3124422.
DOI: 10.1186/1471-2172-12-29.
Codelivery of a DNA vaccine and a protein vaccine with aluminum phosphate stimulates a potent and multivalent immune response.
Kwissa M, Lindblad E, Schirmbeck R, Reimann J
J Mol Med (Berl). 2003; 81(8):502-10.
PMID: 12879151
DOI: 10.1007/s00109-003-0452-9.
Phosphodiester CpG oligonucleotides as adjuvants: polyguanosine runs enhance cellular uptake and improve immunostimulative activity of phosphodiester CpG oligonucleotides in vitro and in vivo.
Dalpke A, Zimmermann S, Albrecht I, Heeg K
Immunology. 2002; 106(1):102-12.
PMID: 11972638
PMC: 1782689.
DOI: 10.1046/j.1365-2567.2002.01410.x.
Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition.
Bauer S, Kirschning C, Hacker H, Redecke V, Hausmann S, Akira S
Proc Natl Acad Sci U S A. 2001; 98(16):9237-42.
PMID: 11470918
PMC: 55404.
DOI: 10.1073/pnas.161293498.
Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant.
Al-Mariri A, Tibor A, Mertens P, De Bolle X, Michel P, Godefroid J
Infect Immun. 2001; 69(8):4816-22.
PMID: 11447155
PMC: 98569.
DOI: 10.1128/IAI.69.8.4816-4822.2001.
The response of human B lymphocytes to oligodeoxynucleotides.
Liang H, Lipsky P
Springer Semin Immunopathol. 2000; 22(1-2):63-75.
PMID: 10944801
DOI: 10.1007/s002810000017.
A role for NF-kappaB-dependent gene transactivation in sunburn.
Abeyama K, Eng W, Jester J, Vink A, Edelbaum D, Cockerell C
J Clin Invest. 2000; 105(12):1751-9.
PMID: 10862790
PMC: 378515.
DOI: 10.1172/JCI9745.
Extending the CD4(+) T-cell epitope specificity of the Th1 immune response to an antigen using a Salmonella enterica serovar typhimurium delivery vehicle.
Lo-Man R, Langeveld J, Deriaud E, Jehanno M, Rojas M, CLEMENT J
Infect Immun. 2000; 68(6):3079-89.
PMID: 10816447
PMC: 97535.
DOI: 10.1128/IAI.68.6.3079-3089.2000.
The effects of DNA containing CpG motif on dendritic cells.
Behboudi S, Chao D, Klenerman P, Austyn J
Immunology. 2000; 99(3):361-6.
PMID: 10712665
PMC: 2327178.
DOI: 10.1046/j.1365-2567.2000.00979.x.
Educating T cells: early events in the differentiation and commitment of cytokine-producing CD4+ and CD8+ T cells.
Kelso A
Springer Semin Immunopathol. 2000; 21(3):231-48.
PMID: 10666771
DOI: 10.1007/BF00812255.
Immunostimulatory bacterial DNA sequences activate dendritic cells and promote priming and differentiation of CD8+ T cells.
Tascon R, Ragno S, Lowrie D, Colston M
Immunology. 2000; 99(1):1-7.
PMID: 10651934
PMC: 2327138.
DOI: 10.1046/j.1365-2567.2000.00941.x.
DNA vaccination favours memory rather than effector B cell responses.
Laylor R, Porakishvili N, de Souza J, Playfair J, Delves P, Lund T
Clin Exp Immunol. 1999; 117(1):106-12.
PMID: 10403923
PMC: 1905479.
DOI: 10.1046/j.1365-2249.1999.00941.x.
CpG-containing oligonucleotides are efficient adjuvants for induction of protective antiviral immune responses with T-cell peptide vaccines.
Oxenius A, Martinic M, Hengartner H, Klenerman P
J Virol. 1999; 73(5):4120-6.
PMID: 10196308
PMC: 104191.
DOI: 10.1128/JVI.73.5.4120-4126.1999.